Rylan Hanks | Director, Regulatory and R&D Policy
Amgen Inc

Rylan Hanks, Director, Regulatory and R&D Policy, Amgen Inc

Dr. Rylan Hanks’ expertise is in global regulatory and health policy, with a focus on the United States. He currently serves as a Director of Global Regulatory and R&D Policy at Amgen. Prior to this role, he worked at the U.S. Food and Drug Administration within the Office of Generic Drugs. Additionally, Dr. Hanks has extensive experience in pharmacy practice and policy matters through membership and engagement with state, national, and international pharmacy organizations.

Appearances:



World Orphan Drug Congress USA 2018 - Conference Day Two @ 14:01

ROUNDTABLE 1: Incentives ecosystem - current political, regulatory and legislative climate in the EU and US, around orphan product incentives

back to speakers